Seo DH, Min KW, Sohn HS, Kim SY, et al. Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial. Diabetes Obes Metab 2025 Nov 14. doi: 10.1111/dom.70257.
PMID: 41236870